CAPLIN POINT LAB LTD SHARE PRICE [LIVE]
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Dec 22 | Sep 22 |
|---|---|---|
| Promoters (Change:-0.08) | 68.8% | 68.88% |
| FIIs (Change:0.09) | 2.24% | 2.15% |
| Mutual Funds (Change:-0.01) | 1.04% | 1.05% |
| Insurance Companies (Change:0.00) | 0% | 0% |
| Other DIIs (Change:0.01) | 0.08% | 0.07% |
| Non Institution (Change:-0.01) | 27.84% | 27.85% |
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in CAPLIN POINT LAB LTD
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
CAPLIPOINT News
Frequently Asked Questions
What is the Share price of CAPLIN POINT LAB LTD. (CAPLIPOINT)?
Can I buy CAPLIN POINT LAB LTD. (CAPLIPOINT) shares?
How do I buy CAPLIN POINT LAB LTD. (CAPLIPOINT) from Angel One?
- Direct investment: You can buy CAPLIN POINT LAB LTD. (CAPLIPOINT) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to CAPLIN POINT LAB LTD. (CAPLIPOINT) shares.
In which sector do CAPLIN POINT LAB LTD. (CAPLIPOINT) belong?
About CAPLIPOINT
Today's live share price for CAPLIN POINT LAB LTD is NSE: ₹ 608.30, BSE: ₹ 609.00 with a current market capitalization of .
Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India. The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.
Read more
